Is KMMIF or MRK a better dividend investment in 2026?

KMMIF currently yields 1538.46% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: KMMIF offers higher current income.

What is the dividend yield difference between KMMIF and MRK?

KMMIF has a forward dividend yield of 1538.46% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1535.70 percentage points.

Home › Compare › KMMIF vs MRK

KMMIF vs MRK: Dividend Comparison 2026

KMMIF yields 1538.46% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KMMIF wins by $883991768.06M in total portfolio value

INVESTMENT

TIME HORIZON10 years

KMMIF

● Live price

1538.46%

Share price

$0.13

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$883991768.11M

Annual income

$783,774,560,703,885.50

Full KMMIF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — KMMIF vs MRK

📍 KMMIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KMMIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KMMIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KMMIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KMMIF

Annual income on $10K today (after 15% tax)

$130,769.23/yr

After 10yr DRIP, annual income (after tax)

$666,208,376,598,302.60/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, KMMIF beats the other by $666,208,376,589,974.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KMMIF + MRK for your $10,000?

KMMIF: 50%MRK: 50%

100% MRK50/50100% KMMIF

Portfolio after 10yr

$441995884.08M

Annual income

$391,887,280,356,841.80/yr

Blended yield

88.66%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KMMIF

No analyst data

Altman Z

524.3

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KMMIF buys

MRK buys

No recent congressional trades found for KMMIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKMMIFMRK

Forward yield	1538.46% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$883991768.11M ✓	$56.8K
Annual income after 10y	$783,774,560,703,885.50 ✓	$9,798.13
Total dividends collected	$876714122.30M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: KMMIF vs MRK ($10,000, DRIP)

Year	KMMIF Portfolio	KMMIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$164,546	$153,846.15	$11,206	$366.19	+$153.3K → KMMIF
2	$2,541,933	$2,365,868.50	$12,650	$502.35	+$2.53M → KMMIF
3	$36,877,139	$34,157,271.11	$14,407	$694.19	+$36.86M → KMMIF
4	$502,577,470	$463,118,930.88	$16,585	$967.82	+$502.56M → KMMIF
5	$6,436,433,977	$5,898,676,084.35	$19,342	$1,363.89	+$6436.41M → KMMIF
6	$77,488,345,446	$70,601,361,090.44	$22,913	$1,947.19	+$77488.32M → KMMIF
7	$877,278,013,079	$794,365,483,451.57	$27,662	$2,823.89	+$877277.99M → KMMIF
8	$9,343,682,184,854	$8,404,994,710,859.21	$34,159	$4,173.35	+$9343682.15M → KMMIF
9	$93,660,941,503,130	$83,663,201,565,336.92	$43,337	$6,308.80	+$93660941.46M → KMMIF
10	$883,991,768,112,235	$783,774,560,703,885.50	$56,776	$9,798.13	+$883991768.06M → KMMIF

KMMIF vs MRK: Complete Analysis 2026

KMMIF — Stock

First Uranium Resources Ltd. engages in the acquisition, exploration, and evaluation of mineral resource properties in Canada. The company primarily explores for gold. It owns a 100% interest in the Black Duck project consisting of two mineral titles covering approximately 1,621.9 hectares in south-central British Columbia. The company was formerly known as Karam Minerals Inc. and changed its name to First Uranium Resources Ltd. in January 2022. First Uranium Resources Ltd. was incorporated in 2016 and is based in Vancouver, Canada.

Full KMMIF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this KMMIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KMMIF vs SCHD KMMIF vs JEPI KMMIF vs O KMMIF vs KO KMMIF vs MAIN KMMIF vs JNJ KMMIF vs ABBV KMMIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.